DTx Pharma, Inc. — Form D/A
DTx Pharma, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2019-09-20. The offering totals $12.5M, of which $12.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-09-20
- Form: D/A
- Accession: 0001715954-19-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $12.5M
- Amount sold: $12.0M
- Remaining: $500K
- Minimum investment: $10K
- Investors: 60
- Date of first sale: 2019-04-12
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-337920
Issuer
- Name: DTx Pharma, Inc.
- CIK: 0001715954
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 3210 MERRYFIELD ROW na, SAN DIEGO, CA, 92121
- Phone: 858-792-3601
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Jeffrey T Friedman | Director | SAN DIEGO, CA |
| John T Grundy | Director | SAN DIEGO, CA |
| Arthur T Suckow | Director | SAN DIEGO, CA |
| Arthur T Suckow | Executive Officer | SAN DIEGO, CA |
| Andrew Adams | Director | Los Angeles, CA |
| Matthew Hammond | Director | VANCOUVER, A1 |
| Jeffrey Friedman | Director | Grass Lake, MI |
| Jeffrey Friedman | Executive Officer | Grass Lake, MI |
| Daniel Becker | Director | Cambridge, MA |
| Arthur Suckow | Director | San Diego, CA |
| Arthur Suckow | Executive Officer | San Diego, CA |
| John Rundy | Director | San Diego, CA |
| Niki Upper | Executive Officer | San Diego, CA |
| Tim Scott | Director | San Diego, CA |
| John Grundy | Director | San Diego, CA |
| Arthur T Suckow | Related Person | SAN DIEGO, CA |
| John T Grundy | Related Person | SAN DIEGO, CA |
| Jeffrey T Friedman | Related Person | SAN DIEGO, CA |
Other filings by this issuer (5)
More